Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy

High risk neuroblastoma is responsible for 15% of deaths in pediatric cancer patients. The introduction of anti-GD2 immunotherapy has significantly improved outcomes but there is still only approximately a 50% 5 year event-free-survival for these children and improvements in treatments are urgently...

Descripción completa

Detalles Bibliográficos
Autores principales: Slattery, Karen, Breheny, Megan, Woods, Elena, Keating, Sinead, Brennan, Kiva, Rooney, Caroline, Augustine, Sindhu, Ryan, Aishling, Owens, Cormac, Gardiner, Clair M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585418/
https://www.ncbi.nlm.nih.gov/pubmed/36276144
http://dx.doi.org/10.3389/fonc.2022.1004871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585418/
https://www.ncbi.nlm.nih.gov/pubmed/36276144
http://dx.doi.org/10.3389/fonc.2022.1004871

Ejemplares similares